Nextstellis

Chemical Namedrospirenone and estetrol
Dosage FormTablet (oral; drospirenone/estetrol 3 mg/14.2 mg)
Drug ClassMultiple
SystemGenitourinary
CompanyMayne Pharma
Approval Year2021

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy.
Last updated on 1/12/2023

More on this drug: Clinical Trials

Document TitleYearSource
Nextstellis (drospirenone and estetrol) Prescribing Information.2022Mayne Pharma, Greenville, NC
Document TitleYearSource
Australian public assessment report for Nextstellis. 2022Australian Government: Department of Health